To develop its current pipeline AND CRGN's?I'd think that a significant (dilutive) secondary will be needed during 2010 to raise cash, especially if any drug prospects have viability. What are the thoughts?
with crgn they ll have money till 2012
cash not the problem...they are good to go'
They have quite a bit of cash to operate on. Especially considering Pfizer is paying for part of it.